Journal: Arteriosclerosis, Thrombosis, and Vascular Biology
Article Title: Single-Cell RNA-Seq Reveals Coronary Heterogeneity and Identifies CD133 + TRPV4 high Endothelial Subpopulation in Regulating Flow-Induced Vascular Tone in Mice
doi: 10.1161/atvbaha.123.319516
Figure Lengend Snippet: Figure 3. Identification of mice CD133+TRPV4high coronary artery endothelial cells (ECs; CAECs). A, Left, T-distributed stochastic neighbor embedding (t-SNE) of CAECs from all coronary arterial branches, cluster 3 (CD133+TRPV4high) CAECs colored in red; Middle, t-SNE of CAECs in each coronary artery branch. Right, Summarizes cluster 3 (CD133+TRPV4high) CAEC composition in a bar graph. B, Heatmap of the expression of GPCRs (G-protein-coupled receptors) and flow-related genes in cluster 3 (CD133+TRPV4high) CAECs. C, Dot plots of the top 10 enriched Kyoto Encyclopedia of Genes and Genomes pathways of significantly changed marker genes in the cluster 3 CAECs subpopulation. Dot size, member of enriched genes in each pathway; color, enrichment P value. D, Violin plots showing the distribution of expression of Trpv4 and Prom1 in CD133+TRPV4high and TRPV4low ECs. E, Validation of the presence of TRPV4-eGFP (transient receptor potential vanilloid 4-enhanced green fluorescent protein) expression by en face immunofluorescence in coronary branches. CDH5, EC marker. Scale bar, 50 µm. n=4 for each branch. F, Representative figure showing the results of CD133 sorting of CAECs, CD144 was used as an EC sorting marker. G, Western blots of TRPV4 expression in CD133+ and CD133− CAECs from wild-type (WT) and endothelium-specific TRPV4 knockout (TRPV4EC −/−) mice. CAECs represent CAECs before cell sorting; CD133+ and CD133− represent CD133-sorted CAECs. CAECs were obtained from 6 WT or TRPV4EC −/− mice and then applied in a Western blot as 6 replicates using 1-way ANOVA. *P<0.001 vs CAECs, #P<0.001 vs CD133+. Ordinary 1-way ANOVA was performed, and P values were adjusted with Dunnett test. Data are expressed as the mean±SEM. cAMP indicates cyclic adenosine monophosphate; cGMP, cyclic guanosine monophosphate; Cir-LCA, circumflex left coronary artery; Des-LCA, descending left coronary artery; FC, fold change; GPCR, G-protein- coupled receptor; PKG, protein kinase G; RCA, right coronary artery; and TRP, transient receptor potential.
Article Snippet: Primary antibodies for TRPV4 (No. ACC-034-AO; Alomone Labs, Israel, 1:200), GAPDH (No. sc-365062; Santa Cruz Biotechnology, 1:500), and corresponding secondary antibodies to each primary antibody were used.
Techniques: Expressing, Marker, Biomarker Discovery, Immunofluorescence, Western Blot, Knock-Out, FACS